Signal Transduction G-Protein Coupled Receptors

Understanding G-protein coupled receptors (GPCRs) is fundamental to medicine because these proteins are the target for over one-third of all FDA-approved drugs. From regulating heart rate and mood to enabling vision and smell, GPCRs translate an external chemical message into a precise intracellular response. Mastering their signaling cascades, which hinge on heterotrimeric G proteins and second messengers, is essential for predicting drug effects, understanding disease pathophysiology, and excelling on the MCAT's biological sciences section.

The GPCR Structure and Activation Mechanism

A G-protein coupled receptor (GPCR) is a seven-transmembrane domain protein embedded in the plasma membrane. Its extracellular region contains a binding site for a specific signaling molecule, or ligand, which can be a hormone, neurotransmitter, or photon. The intracellular portion interacts with a heterotrimeric G protein, which is composed of three distinct subunits: alpha ($\alpha$), beta ($\beta$), and gamma ($\gamma$). In the inactive state, the G$\alpha$ subunit is bound to GDP and the entire G protein complex is loosely associated with the receptor.

The signaling cascade begins when a ligand binds to the GPCR's extracellular site. This binding induces a conformational change in the receptor's structure. This change acts like a key turning in a lock, allowing the receptor to interact more tightly with the heterotrimeric G protein. This interaction causes the G$\alpha$ subunit to exchange its bound GDP for GTP. The energy from this exchange triggers another conformational change, causing the GTP-bound G$\alpha$ subunit to dissociate from the G$\beta \gamma$ dimer. Both the active G$\alpha$-GTP complex and the freed G$\beta \gamma$ dimer are now mobile signaling molecules that can diffuse along the membrane to interact with various effector proteins, initiating different downstream pathways.

Major G Protein Classes and Their Effectors

There are several families of G$\alpha$ subunits, each coupling to different effector systems. The three most critical for medical studies and the MCAT are G${}_s$, G${}_i$, and G${}_q$.

G${}_s$ (Stimulatory): When activated, G${}_{\alpha }$_s-GTP moves to and stimulates the membrane-bound enzyme adenylyl cyclase. This enzyme catalyzes the conversion of ATP to the second messenger cyclic AMP (cAMP). Think of G${}_s$ as an accelerator for cAMP production. A classic example is the binding of epinephrine to $\beta$-adrenergic receptors in the heart, which activates G${}_s$, increases cAMP, and ultimately increases heart rate and contractility.

G${}_i$ (Inhibitory): In contrast, active G${}_{\alpha }$i-GTP inhibits adenylyl cyclase, decreasing the production of cAMP. The GMATHINLINE20 dimer released from GMATHINLINE21 proteins can also have its own effects, such as opening potassium channels in heart cells, which slows heart rate. The overall effect of GMATHINLINE22 activation is often oppositional to GMATHINLINE23. An example is the binding of acetylcholine to muscarinic (M2) receptors in the heart, which activates GMATHINLINE24_, lowers cAMP, and slows heart rate.

G${}_q$: This class takes a different route. G${}_{\alpha }$_q-GTP activates the membrane effector phospholipase C (PLC-$\beta$). PLC cleaves a membrane phospholipid called PIP${}_2$ into two critical second messengers: diacylglycerol (DAG), which remains in the membrane, and inositol trisphosphate (IP${}_3$), which diffuses into the cytoplasm.

Second Messengers and Downstream Signaling

The primary role of second messengers like cAMP, IP${}_3$, and DAG is to amplify the initial signal and distribute it within the cell.

The cAMP Pathway: The rise in intracellular cAMP activates the primary effector protein kinase A (PKA). cAMP binds to the regulatory subunits of PKA, causing them to dissociate and activate the catalytic subunits. Active PKA then phosphorylates numerous target proteins, altering their activity. For instance, in liver cells, PKA phosphorylates and activates glycogen phosphorylase, promoting glycogen breakdown to release glucose during a fight-or-flight response.

The IP${}_3$ and DAG Pathway: The two products of PLC action have coordinated effects. IP${}_3$ diffuses through the cytosol and binds to ligand-gated calcium channels on the surface of the endoplasmic reticulum (ER). This binding triggers the release of stored calcium ions ($C{a}^{2+}$) from the ER into the cytoplasm, creating a rapid spike in intracellular $C{a}^{2+}$ concentration. DAG, along with the released calcium, activates another key kinase called protein kinase C (PKC). The simultaneous activation of PKC and the calcium signal (which can activate other proteins like calmodulin) allows for a complex, multifaceted cellular response, such as smooth muscle contraction or neuronal excitation.

Signal Termination and Regulation

For a signaling pathway to be precise, it must be able to turn off. This termination is achieved at multiple levels. First, the ligand concentration drops, causing it to unbind from the GPCR. Intrinsically, the G$\alpha$ subunit has GTPase activity; it slowly hydrolyzes its bound GTP back to GDP. Once GTP is hydrolyzed, the G$\alpha$-GDP subunit reassociates with the G$\beta \gamma$ dimer, reforming the inactive heterotrimer. This hydrolysis is often accelerated by Regulator of G protein Signaling (RGS) proteins. Furthermore, second messengers are degraded: cAMP is broken down by phosphodiesterases, and calcium is actively pumped back into the ER or out of the cell. Without constant activation, the system resets to its basal state.

Common Pitfalls

1. Confusing G Protein Subunit Roles: A frequent MCAT trap is misattributing actions to the wrong subunit. Remember: The G$\alpha$ subunit (when bound to GTP) primarily interacts with effector enzymes like adenylyl cyclase or PLC. The G$\beta \gamma$ dimer can also activate effectors (e.g., certain potassium channels), especially when released from G${}_i$ proteins. Don't assume only the $\alpha$ subunit is active.
2. Mixing Up Second Messenger Pathways: It's easy to conflate the actors in the cAMP and IP${}_3$/DAG pathways. Use this mnemonic: G${}_q$ "quenches" your thirst for two messengers (IP${}_3$ and DAG), while G${}_s$ gives you a single "sip" (cAMP). Also, remember IP${}_3$ releases calcium from internal stores (ER), it does not open channels on the plasma membrane.
3. Overlooking Signal Amplification: A single ligand-bound receptor can activate multiple G proteins, and each activated enzyme (like adenylyl cyclase) can produce many second messenger molecules. This cascade creates tremendous signal amplification, a key concept often tested in the context of hormonal sensitivity.
4. Forgetting About Termination: Signaling is not just about turning on; it's equally about turning off. Be prepared to identify the mechanism that inactivates any given step in a pathway (e.g., GTP hydrolysis, phosphodiesterase action, calcium pumps).

Summary

• GPCRs are seven-transmembrane receptors that, upon ligand binding, activate heterotrimeric G proteins by facilitating the exchange of GDP for GTP on the G$\alpha$ subunit.
• The major G protein classes are G${}_s$ (stimulates adenylyl cyclase to produce cAMP), G${}_i$ (inhibits adenylyl cyclase), and G${}_q$ (activates phospholipase C to produce IP${}_3$ and DAG).
• Key second messengers include cAMP (activates PKA), IP${}_3$ (releases $C{a}^{2+}$ from the ER), and DAG (with $C{a}^{2+}$, activates PKC).
• Signals are terminated by GTP hydrolysis on the G$\alpha$ subunit, degradation of second messengers, and receptor internalization.
• For the MCAT, focus on the logical flow from receptor → G protein → effector enzyme → second messenger → kinase → cellular response, and be able to compare and contrast the G${}_s$ and G${}_q$ pathways.